APOGEYE Pharma

Apogee Pharmaceuticals is a private, early-stage biotechnology company focused on women's health. The company is based in Greater Vancouver, British Columbia, and operates a wet-lab research facility focused on mechanism-driven drug discovery. Apogee is building a preclinical pipeline of novel therapeutics and diagnostics for high-unmet-need conditions including endometriosis and adenomyosis, while also advancing endocannabinoid system-related programs. Its discovery strategy uses human genetics, multi-omics, translational biology, and AI-enabled prioritization through its proprietary Translational RubriX platform. The company appears to be backed by a healthcare-focused investment firm and is pursuing both internal discovery and externally sourced assets.